April 16, 2015 – Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation (EIF), is increasing national awareness about one of the deadliest cancers, lung cancer, in a new public service announcement (PSA), which is supported by a charitable donation from Bristol-Myers Squibb.
March 24, 2015 - Stand Up To Cancer (SU2C) and PBS LearningMedia announced today The EMPEROR Science Award Program, an initiative that will encourage students from disadvantaged high schools to pursue careers in science, with a particular emphasis on cancer research through a year of mentorship with a scientist from a leading research institution or industry.
March 4, 2015— The American Association for Cancer Research (AACR) is now accepting submissions of ideas for the Stand Up To Cancer (SU2C)-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Translational Research Grant. The grant provides up to $12 million over a three-year period for research on prevention, diagnosis, or treatment of pancreatic cancer by a “Dream Team” of top scientists.
SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Supports New Immunotherapy TrialFebruary 26, 2015 - Aduro Biotech, Inc. today announced the initiation of an investigator-sponsored Phase 2 clinical trial of the company’s immuno-oncology product candidates GVAX Pancreas and CRS-207 in combination with Bristol-Myers Squibb’s Opdivo (nivolumab), a monoclonal antibody against programmed death-1 receptor (PD-1).
February 4, 2015 -- WETA, the flagship public media station for Washington, D.C., announced today, World Cancer Day, that it has produced a 30-minute television special titled Cancer: The Emperor of All Maladies — A Conversation.